Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma

We are proud to announce that in a collaboration with the UCSD Moores Cancer Center, with colleagues at Sun Yet-sun University Cancer Center and other collaborating institutions, we have developed a new diagnostic and prognosis method for early detection of hepatocellular carcinoma (HCC), based on a simple blood sample containing circulating tumor DNA.

Full Article may be found on the October 9 issue of Nature Materials. PDF Full Text.

Continue reading “Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma”